Remission of ulcerative colitis flare-up induced by nivolumab

BACKGROUND: Immune checkpoint inhibitors (ICIs) have been used to treat many cancers, but ICIs are rarely administered for malignant tumours coexisting with inflammatory bowel disease. METHODS AND RESULTS: We report a 77-year-old man experiencing an ulcerative colitis (UC) flare-up after receiving n...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwamoto, Maho, Kato, Kimitoshi, Moriyama, Mitsuhiko, Yamaguchi, Kenya, Takahashi, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415029/
https://www.ncbi.nlm.nih.gov/pubmed/32458394
http://dx.doi.org/10.1007/s00384-020-03638-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415029/
https://www.ncbi.nlm.nih.gov/pubmed/32458394
http://dx.doi.org/10.1007/s00384-020-03638-3

Ejemplares similares